Our Team

Founded by Hans Udo (Strategic Management) and Ronald Burggrave (Business Development & Molecular Biology), Genetic Tools Europe brings together a specialized team focused on the early detection of cancer and infectious diseases.

Our mission is to deliver cost-effective, life-saving diagnostics. Our core expertise is rounded out by Anton van den Ouden, who leads our Quality Control and Assurance (QC/QA) efforts, and Isabelle Zamperlini, who heads our Marketing Communications. Together with our partners at Genetic Tools LLC, we are redefining the limits of PCR technology to drive a new era of preventive care.

Global Collaboration & Innovation

Our partnership with the Genetic Tools LLC team (Rancho Cucamonga, CA, USA) leverages their pioneering PAP-PCR based technology and scientific mastery. By combining LLC’s innovation with Genetic Tools Europe’s focused approach to market identification, we are bringing this platform to the forefront of genetic analysis—superseding traditional PCR technologies.

Our proprietary platform is designed to open a new era of diagnostics, beginning with the monitoring of cancer recurrence (relapse) and expanding into a method for detecting hundreds of disease-causing mutations and biomarkers.

Strategic Foundation & Market Position

A robust IP strategy and continuous innovation reinforce our global standing:

35+ US and Global Patents: Protecting our core technologies.
Pioneering Technology: Originators of PAP and RT-PAP technologies with ongoing product development.
Unmatched Know-How: Expertise developed directly by the inventor of PAP and RT-PAP.
Freedom to Operate: Comprehensive assessments indicate no infringement risk in major markets.
Future-Ready: Ongoing advancements in NGS library preparation and thermophilic reverse transcriptase to further boost sensitivity and speed.